Impaired HMG-CoA Reductase Activity Caused by Genetic Variants or Statin Exposure: Impact on Human Adipose Tissue, β-Cells and Metabolome

Inhibition of 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase is associated with an increased risk of new-onset type 2 diabetes. We studied the association of genetic or pharmacological HMG-CoA reductase inhibition with plasma and adipose tissue (AT) metabolome and AT metabolic pathways. We also...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarsenbayeva, Assel, Jui, Bipasha Nandi, Fanni, Giovanni, Barbosa, Pedro, Ahmed, Fozia, Kristófi, Robin, Cen, Jing, Chowdhury, Azazul, Skrtic, Stanko, Bergsten, Peter, Fall, Tove, Eriksson, Jan W., Pereira, Maria J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468287/
https://www.ncbi.nlm.nih.gov/pubmed/34564389
http://dx.doi.org/10.3390/metabo11090574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468287/
https://www.ncbi.nlm.nih.gov/pubmed/34564389
http://dx.doi.org/10.3390/metabo11090574

Ejemplares similares